Edwards Crashes 31% After Slashing Guidance For Its Biggest Moneymaker
Investor's Business DailyEdwards Lifesciences stock plummeted Thursday after the medtech cut its outlook for TAVR sales following a mixed second-quarter report.
The post Edwards Crashes 31% After Slashing Guidance For Its Biggest Moneymaker appeared first on Investor's Bu…